Literature DB >> 33853644

Correction to: A case report of Phelan-McDermid syndrome: preliminary results of the treatment with growth hormone therapy.

Rui Jin Xie1, Tian Xiao Li1, Chenyu Sun2, Ce Cheng3, Jinlin Zhao1, Hua Xu1, Yueying Liu4.   

Abstract

Entities:  

Year:  2021        PMID： 33853644      PMCID： PMC8045318          DOI： 10.1186/s13052-021-01038-z

Source DB:  PubMed          Journal:  Ital J Pediatr        ISSN： 1720-8424            Impact factor:   2.638


× No keyword cloud information.
Correction to: Ital J Pediatr 47, 49 (2021) https://doi.org/10.1186/s13052-021-01003-w Figure 1 was replaced with a more appropriate image due to privacy issues in the original article [1]. All authors agreed to this correction.
Fig. 1

Photograph of patient: rounded face

Photograph of patient: rounded face
  1 in total

1.  A case report of Phelan-McDermid syndrome: preliminary results of the treatment with growth hormone therapy.

Authors:  Rui Jin Xie; Tian Xiao Li; Chenyu Sun; Ce Cheng; Jinlin Zhao; Hua Xu; Yueying Liu
Journal:  Ital J Pediatr       Date:  2021-03-04       Impact factor: 2.638
  1 in total
  3 in total

Review 1.  Genetic Findings as the Potential Basis of Personalized Pharmacotherapy in Phelan-McDermid Syndrome.

Authors:  Brianna Dyar; Erika Meaddough; Sara M Sarasua; Curtis Rogers; Katy Phelan; Luigi Boccuto
Journal:  Genes (Basel)       Date:  2021-07-30       Impact factor: 4.096

2.  A proof-of-concept study of growth hormone in children with Phelan-McDermid syndrome.

Authors:  S Sethuram; T Levy; J Foss-Feig; D Halpern; S Sandin; P M Siper; H Walker; J D Buxbaum; R Rapaport; A Kolevzon
Journal:  Mol Autism       Date:  2022-01-29       Impact factor: 7.509

3.  Phelan-McDermid Syndrome in Pediatric Patients With Novel Mutations: Genetic and Phenotypic Analyses.

Authors:  Liang Chen; Zhi-Ye Yao; Xiangtao Wu; Shao-Ru He; Yu-Mei Liu; Xue-Yan Wang; De-Zhi Cao; Xing-Kun Yang; Jian-Bo Zhao; Zi Ren; Hong Li; Zheng Pei; Hong-Ke Ding; Zhi-Chun Feng
Journal:  Front Pediatr       Date:  2022-08-23       Impact factor: 3.569
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.